Clinical Trial
Accepted on 25 Aug 2025
B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the east coastal region of China
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders